L
Lynn Sanders
Researcher at National Health Service
Publications - 4
Citations - 1292
Lynn Sanders is an academic researcher from National Health Service. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 2, co-authored 2 publications receiving 810 citations.
Papers
More filters
Journal ArticleDOI
The 2017 international classification of the Ehlers-Danlos syndromes
Fransiska Malfait,Clair A. Francomano,Peter H. Byers,John W. Belmont,Britta Berglund,James H. Black,Lara Bloom,Jessica M Bowen,Angela F. Brady,Nigel Burrows,Marco Castori,Helen Cohen,Marina Colombi,Serwet Demirdas,Julie De Backer,Anne De Paepe,Sylvie Fournel-Gigleux,Michael Frank,Neeti Ghali,Cecilia Giunta,Rodney Grahame,Alan Hakim,Xavier Jeunemaitre,Diana Johnson,Birgit Juul-Kristensen,Ines Kapferer-Seebacher,Hanadi Kazkaz,Tomoki Kosho,Mark E. Lavallee,Howard P. Levy,Roberto Mendoza-Londono,Melanie Pepin,F. Michael Pope,Eyal Reinstein,Leema Robert,Marianne Rohrbach,Lynn Sanders,Glenda Sobey,Tim Van Damme,Anthony Vandersteen,Caroline van Mourik,Nicol C. Voermans,Nigel Wheeldon,Johannes Zschocke,Brad T. Tinkle +44 more
TL;DR: The International EDS Consortium proposes a revised EDS classification, which recognizes 13 subtypes, and revised the clinical criteria for hypermobile EDS in order to allow for a better distinction from other joint hypermobility disorders.
Journal ArticleDOI
Diagnosis, natural history, and management in vascular Ehlers–Danlos syndrome
Peter H. Byers,John W. Belmont,James H. Black,Julie De Backer,Michael Frank,Xavier Jeunemaitre,Diana Johnson,Melanie Pepin,Leema Robert,Lynn Sanders,Nigel Wheeldon +10 more
TL;DR: Recommendations for management represent a consensus of an international group of specialists with a broad aggregate experience in the care of individuals with vascular EDS that will need to be assessed on a regular basis as new information develops.
Journal ArticleDOI
Trends in characteristics and outcomes among US adults hospitalised with COVID-19 throughout 2020: an observational cohort study
John H Page,Ajit Londhe,Corinne G. Brooks,Jie Zhang,J. Michael Sprafka,Corina W Bennett,Megan Braunlin,Carolyn A. Brown,Prista Charuworn,Alvan Cheng,Karminder S. Gill,Fang He,Junjie Ma,Jeffrey Petersen,Olulade Ayodele,Ying Bao,Katherine B Carlson,Shun-Chiao Chang,G Devercelli,Michele Jonsson-Funk,Jenny Jiang,Hillary A. Keenan,Kaili Ren,Kimberly A. Roehl,Lynn Sanders,Lu-Juan Wang,Zhongyuan Wei,Qian Xia,Peter Yu,Linyun Zhou,Julia Zhu,Kathleen Gondek,Cathy W. Critchlow,Brian D. Bradbury +33 more
TL;DR: The incidence of adverse clinical outcomes remains high among CO VID-19 patients with clinical diagnosis only, and patients with COVID-19 entering the hospital are at elevated risk of adverse outcomes.
Journal ArticleDOI
Observational study evaluating wait time and clinical outcomes in patients (pts) with diffuse large B-cell lymphoma (DLBCL) who received chimeric antigen receptor (CAR) T-cell therapy (T-CT).
TL;DR: Results from this study show evidence of channeling bias which is an important consideration for evaluating real-world data to construct external control arms and no meaningful differences in PFS between wait times in DLBCL pts in the United States are shown.